English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/221179
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Searching for effective antiviral small molecules against influenza A virus: A patent review

AuthorsGinex, Tiziana ORCID ; Luque, Francisco Javier
KeywordsInfluenza
Antivirals
M2 proton channel
Neuraminidase
Hemagglutinin
RNA polymerase
Druggable targets
Drug discovery
Issue Date5-Oct-2020
PublisherTaylor & Francis
CitationExpert Opinion on Therapeutic Patents 31 (1) 53-66 (2020)
AbstractIntroduction Despite the current interest caused by SARS-Cov-2, influenza continues to be one of the most serious health concerns, with an estimated 1 billion cases of influenza across the globe, including 3-5 million severe cases and 290,000-650,000 deaths worldwide.
Areas covered This manuscript reviews the efforts made in the development of small molecules for the treatment of influenza virus, primarily focused on patent applications in the last five years. Attention is paid to compounds targeting key functional viral proteins, such as the M2 channel, neuraminidase, and hemagglutinin, highlighting the evolution toward novel ligands and scaffolds motivated by the emergence of resistant strains. Finally, the discovery of compounds against novel viral targets, such as the RNA-dependent RNA polymerase, is discussed.
Expert opinion The therapeutic potential of antiviral agents is limited by the increasing presence of resistant strains. This should encourage research on novel strategies for therapeutic intervention. In this context, the discovery of arbidol and JNJ7918 against hemagglutinin, and current efforts on RNA-dependent RNA polymerase have disclosed novel opportunities for therapeutic treatment. Future studies should attempt to expand the therapeutic arsenal of anti-flu agents, often in combined therapies, which might be relevant to prevent future health challenges caused by influenza virus.
Description41 p.-6 fig.
Publisher version (URL)https://doi.org/10.1080/13543776.2020.1831471
URIhttp://hdl.handle.net/10261/221179
DOIhttp://dx.doi.org/10.1080/13543776.2020.1831471
ISSN1354-3776
E-ISSN1744-7674
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
eotp_ginex_2020.pdf Embargoed until October 5, 2021Postprint7,27 MBAdobe PDFThumbnail
View/Open    Request a copy
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.